CIK 0000727510
- Non-accelerated filer
- Smaller reporting company
Viskase Holdings, Inc.
Sign in to watch- Ticker
- VISK
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 222372868
- Phone
- +1 630-874-0700
- Business address
- 333 EAST BUTTERFIELD ROAD, SUITE 400, LOMBARD, IL, 60148
- Former names
- ENZON PHARMACEUTICALS, INC., ENZON PHARMACEUTICALS INC, ENZON PHARMACEUTICALS INC, ENZON PHARMACEUTICAL INC, ENZON INC
- 4/A Open-market buy Director bought 10,000 shares at an average $3.22 ($32,211)
- 4 Open-market buy Director bought 15,000 shares at $3.28 ($49,271)
- 4 Open-market buy Director bought 5,970 shares at an average $3.20 ($19,113)
- 4 Open-market buy Chairman, CEO & President bought 50,000 shares at $3.28 ($164,035)
- 4 Exercise or conversion EVP, R&D, Chief Scientific Ofc acquired 15,000 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 10,417 shares (grant or award)
- 4 Grant or award Director acquired 10,417 shares (grant or award)
- 4 Grant or award Director acquired 10,417 shares (grant or award)
- 4 Grant or award Director acquired 10,417 shares (grant or award)
- 4 Grant or award Director acquired 10,417 shares (grant or award)
- 4 Grant or award Director acquired 10,417 shares (grant or award)
- 4 Grant or award Director acquired 10,417 shares (grant or award)
- 4 Grant or award Director acquired 8,343 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Exercise or conversion Exec VP Finance, CFO acquired 4,500 shares (option exercise)
- 4 Open-market sale Director sold 15,000 shares at $9.49 ($142,281)
- 4 Exercise or conversion EVP - Technical Operations acquired 4,500 shares (option exercise)
- 4 Exercise or conversion Exec. Vice Pres. HR acquired 4,500 shares (option exercise)
- 4 Open-market sale Director sold 5,487 shares at an average $9.46 ($51,890)
Page 12 of 28 · 560 filings